Meaningful engagement of the patient in rare cancer research: sarcoma as an exemplar

Current Problems in Cancer - Tập 45 - Trang 100772 - 2021
Denise K. Reinke1
1SARC (Sarcoma Alliance for Research through Collaboration), Ann Arbor, MI

Tài liệu tham khảo

Braun, 2003, The history of breast cancer advocacy, Breast J, 9, S101, 10.1046/j.1524-4741.9.s2.13.x Thornton, 2006, Patients and health professionals working together to improve clinical research: where are we going?, Eur J Cancer, 42, 2454, 10.1016/j.ejca.2006.05.022 Ciccarella, 2018, Transforming research: engaging patient advocates at all stages of cancer research, Ann Transl Med, 6, 167, 10.21037/atm.2018.04.46 Deverka, 2012, Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement, J Comp Eff Res, 1, 181, 10.2217/cer.12.7 Perlmutter, 2013, Cancer research advocacy: past, present, and future, Cancer Res, 73, 4611, 10.1158/0008-5472.CAN-12-4553-T Salamone, 2018, Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How, Cancer Res, 78, 5723, 10.1158/0008-5472.CAN-18-1600 Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Rare Disease Act. 2002; Available from: https://www.congress.gov/bill/107th-congress/house-bill/4013. Access date: January 30, 2021. Baker, 2019, The necessity for rigour in rare disease study design, Lancet Oncol, 20, 1190, 10.1016/S1470-2045(19)30323-7 American Cancer Society, Cancer Facts & Figures. 2021, American Cancer Society: Atlanta, Georgia. Kallen, 2021, The 2020 WHO classification: what's new in soft tissue tumor pathology?, Am J Surg Pathol, 45, e1, 10.1097/PAS.0000000000001552 Sbaraglia, 2020, The 2020 WHO classification of soft tissue tumours: news and perspectives, Pathologica, 10.32074/1591-951X-213 NORD Rare Cancer Coalition. 2017 January 30, 2021]; Available from: https://rarediseases.org/get-involved/rare-cancer-coalition/. Access date: January 30, 2021. Campos-Castelló, 2001, [Orphan drugs and orphan diseases], Rev Neurol, 33, 216 Thomas, 2019, The orphan drug act revisited, Jama, 321, 833, 10.1001/jama.2019.0290 SWOG Patient Advocate Resource Guide, SWOG, Editor. 2018. Deverka, 2018, A new framework for patient engagement in cancer clinical trials cooperative group studies, J Natl Cancer Inst, 110, 553, 10.1093/jnci/djy064 Katz, 2012, Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates, Cancer, 118, 4801, 10.1002/cncr.27485 2021 Billingham, 2016, Research methods to change clinical practice for patients with rare cancers, Lancet Oncol, 17, e70, 10.1016/S1470-2045(15)00396-4 Wilson, 2015, Outcomes and endpoints in trials of cancer treatment: the past, present, and future, Lancet Oncol, 16, e32, 10.1016/S1470-2045(14)70375-4 2019